ArthroCare Corporation
12
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
41.7%
5 terminated/withdrawn out of 12 trials
54.5%
-32.0% vs industry average
75%
9 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Anderson Circulating Tumor Cell Burden (CTCB) Study
Role: collaborator
Cost Effectiveness and Efficacy of Kyphoplasty and Vertebroplasty Trial
Role: collaborator
The Long-term Degradation Outcome of Bilok Screws Used for ACL Reconstruction
Role: lead
Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression
Role: lead
Study to Evaluate Recovery From Postoperative Pain After Sleep Apnea Surgery
Role: lead
Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis
Role: lead
Plasma Disc Decompression Versus Conservative Care
Role: lead
Plantar Fasciosis Treatment Using Coblation
Role: lead
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Role: lead
Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement
Role: lead
Coblation-Tonsillotomy vs Electrocautery-Tonsillectomy for the Treatment of Obstructive Sleep Apnea (OSA) in Children
Role: collaborator
Nucleoplasty for Contained Herniated Lumbar Discs
Role: collaborator
All 12 trials loaded